Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323806![]() (US10189809, Compound I-1) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323807![]() (US10189809, Compound I-3) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323808![]() (US10189809, Compound I-26) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323809![]() (US10189809, Compound I-27) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323810![]() (US10189809, Compound I-33) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323811![]() (US10189809, Compound I-42) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323812![]() (US10189809, Compound I-45) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323813![]() (US10189809, Compound I-4) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323814![]() (US10189809, Compound I-49) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323815![]() (US10189809, Compound I-55) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323816![]() (US10189809, Compound I-6) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323817![]() (US10189809, Compound I-61) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323818![]() (US10189809, Compound I-66) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323819![]() (US10189809, Compound I-71) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323820![]() (US10189809, Compound I-72) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323821![]() (US10189809, Compound I-75) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323822![]() (US10189809, Compound I-83) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323823![]() (US10189809, Compound I-84) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323824![]() (US10189809, Compound I-85) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323825![]() (US10189809, Compound I-86) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323826![]() (US10189809, Compound I-87) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323827![]() (US10189809, Compound I-92) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323828![]() (US10189809, Compound I-93) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323829![]() (US10189809, Compound I-96) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM50175274![]() (CHEMBL3809864 | US10189809, Compound I-97) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | CHEMBL PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323831![]() (US10189809, Compound I-98) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323832![]() (US10189809, Compound I-99) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323833![]() (US10189809, Compound I-100) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323834![]() (US10189809, Compound I-101) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323835![]() (US10189809, Compound I-102) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323836![]() (US10189809, Compound I-103) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 5.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323837![]() (US10189809, Compound I-104) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323838![]() (US10189809, Compound I-105) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323839![]() (US10189809, Compound I-106) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323840![]() (US10189809, Compound I-107) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323841![]() (US10189809, Compound I-108) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 2.00E+5 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323842![]() (US10189809, Compound I-109) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323843![]() (US10189809, Compound I-110) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323844![]() (US10189809, Compound I-111) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323845![]() (US10189809, Compound I-112 | US10189809, Compound ...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323846![]() (US10189809, Compound I-113) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323847![]() (US10189809, Compound I-114) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323848![]() (US10189809, Compound I-115) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323849![]() (US10189809, Compound I-116) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323850![]() (US10189809, Compound I-118) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 8.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323851![]() (US10189809, Compound I-119) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323852![]() (US10189809, Compound I-121) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323853![]() (US10189809, Compound I-122) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | 3.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323854![]() (US10189809, Compound I-125) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair | |||||||||||||
Guanylate cyclase soluble subunit alpha-1 (Homo sapiens (Human)) | BDBM323855![]() (US10189809, Compound I-126) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet ![]() | PC cid PC sid UniChem | US Patent | n/a | n/a | n/a | n/a | <2.00E+4 | n/a | n/a | n/a | n/a |
Ironwood Pharmaceuticals, Inc. US Patent | Assay Description Human embryonic kidney cells (HEK293), endogenously expressing soluble guanylate cyclase (sGC), were used to evaluate the activity of test compounds.... | US Patent US10189809 (2019) BindingDB Entry DOI: 10.7270/Q27H1MQ6 | |||||||||||
More data for this Ligand-Target Pair |
Displayed 1 to 50 (of 198 total ) | Next | Last >> |